Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIIIW) Return on Sales (2020 - 2025)

P3 Health Partners' Return on Sales history spans 6 years, with the latest figure at 0.43% for Q4 2025.

  • For Q4 2025, Return on Sales fell 8.0% year-over-year to 0.43%; the TTM value through Dec 2025 reached 0.22%, down 1.0%, while the annual FY2025 figure was 0.22%, 1.0% down from the prior year.
  • Return on Sales reached 0.43% in Q4 2025 per PIIIW's latest filing, down from 0.2% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.08% in Q2 2024 to a low of 16.11% in Q1 2021.
  • Average Return on Sales over 5 years is 1.26%, with a median of 0.2% recorded in 2021.
  • The largest YoY upside for Return on Sales was 1589bps in 2022 against a maximum downside of -315bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.48% in 2021, then crashed by -333bps to 2.06% in 2022, then surged by 90bps to 0.2% in 2023, then crashed by -75bps to 0.35% in 2024, then fell by -24bps to 0.43% in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Return on Sales are 0.43% (Q4 2025), 0.2% (Q3 2025), and 0.12% (Q2 2025).